119 related articles for article (PubMed ID: 38000668)
21. Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy.
Johnson JA; Li JF; Wei X; Lipscomb J; Irlbeck D; Craig C; Smith A; Bennett DE; Monsour M; Sandstrom P; Lanier ER; Heneine W
PLoS Med; 2008 Jul; 5(7):e158. PubMed ID: 18666824
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 drug resistance surveillance among parturient women on anti-retroviral therapy in the Eastern Cape, South Africa: Implications for elimination of mother-to-child transmission.
Adeniyi OV; Obi CL; Goon DT; Iweriebor B; Ajayi AI; Lambert J; Okoh A
J Clin Virol; 2019 Aug; 117():89-95. PubMed ID: 31255794
[TBL] [Abstract][Full Text] [Related]
23. Rapid HIV-1 drug resistance testing in a resource limited setting: the Pan Degenerate Amplification and Adaptation assay (PANDAA).
Kouamou V; Ndhlovu CE; Katzenstein D; Manasa J
Pan Afr Med J; 2021; 40():57. PubMed ID: 34795836
[TBL] [Abstract][Full Text] [Related]
24. Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.
Fisher RG; Smith DM; Murrell B; Slabbert R; Kirby BM; Edson C; Cotton MF; Haubrich RH; Kosakovsky Pond SL; Van Zyl GU
J Clin Virol; 2015 Jan; 62():48-53. PubMed ID: 25542470
[TBL] [Abstract][Full Text] [Related]
25. Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia.
Mohamad S; Deris ZZ; Yusoff NK; Ariffin TA; Shueb RH
Braz J Infect Dis; 2012; 16(3):284-8. PubMed ID: 22729198
[TBL] [Abstract][Full Text] [Related]
26. Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.
Kagan RM; Dunn KJ; Snell GP; Nettles RE; Kaufman HW
AIDS Res Hum Retroviruses; 2019 Aug; 35(8):698-709. PubMed ID: 31169022
[TBL] [Abstract][Full Text] [Related]
27. Use of amplification refractory mutation system PCR assay as a simple and effective tool to detect HIV-1 drug resistance mutations.
Nanfack AJ; Agyingi L; Noubiap JJ; Ngai JN; Colizzi V; Nyambi PN
J Clin Microbiol; 2015 May; 53(5):1662-71. PubMed ID: 25788547
[TBL] [Abstract][Full Text] [Related]
28. HIV type 1 drug resistance patterns among patients failing first and second line antiretroviral therapy in Nairobi, Kenya.
Koigi P; Ngayo MO; Khamadi S; Ngugi C; Nyamache AK
BMC Res Notes; 2014 Dec; 7():890. PubMed ID: 25487529
[TBL] [Abstract][Full Text] [Related]
29. Antiretroviral resistance and genetic diversity of human immunodeficiency virus type 1 isolates from the Federal District, Central Brazil.
Cerqueira DM; Amorim RM; Silva RR; Camara GN; Brígido MM; Martins CR
Mem Inst Oswaldo Cruz; 2004 Dec; 99(8):877-82. PubMed ID: 15761606
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients.
Metzner KJ; Rauch P; Braun P; Knechten H; Ehret R; Korn K; Kaiser R; Sichtig N; Ranneberg B; van Lunzen J; Walter H
J Clin Virol; 2011 Feb; 50(2):156-61. PubMed ID: 21056001
[TBL] [Abstract][Full Text] [Related]
31. Drug resistance mutations and genetic diversity in adults treated for HIV type 1 infection in Mauritania.
Fall-Malick FZ; Tchiakpé E; Ould Soufiane S; Diop-Ndiaye H; Mouhamedoune Baye A; Ould Horma Babana A; Touré Kane C; Lo B; Mboup S
J Med Virol; 2014 Mar; 86(3):404-10. PubMed ID: 24318486
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of HIV drug resistance mutation in the northern Indian population after failure of the first line antiretroviral therapy.
Sinha S; Shekhar RC; Ahmad H; Kumar N; Samantaray JC; Sreenivas V; Khan NH; Mitsuyasu RT
Curr HIV Res; 2012 Sep; 10(6):532-8. PubMed ID: 22716105
[TBL] [Abstract][Full Text] [Related]
33. Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China.
Xie YN; Zhu FX; Zhong YT; Chen YT; Gao Q; Lai XL; Liu JJ; Huang DD; Zhang YN; Chen X
J Antimicrob Chemother; 2021 Oct; 76(11):2975-2982. PubMed ID: 34402512
[TBL] [Abstract][Full Text] [Related]
34. Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort.
Panpradist N; Beck IA; Ruth PS; Ávila-Ríos S; García-Morales C; Soto-Nava M; Tapia-Trejo D; Matías-Florentino M; Paz-Juarez HE; Del Arenal-Sanchez S; Reyes-Terán G; Lutz BR; Frenkel LM
AIDS; 2020 Jul; 34(9):1331-1338. PubMed ID: 32205723
[TBL] [Abstract][Full Text] [Related]
35. A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda.
Troyer RM; Lalonde MS; Fraundorf E; Demers KR; Kyeyune F; Mugyenyi P; Syed A; Whalen CC; Bajunirwe F; Arts EJ
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):235-50. PubMed ID: 18284323
[TBL] [Abstract][Full Text] [Related]
36. Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance.
Rhee SY; Schapiro JM; Saladini F; Zazzi M; Khoo S; Shafer RW
AIDS Res Ther; 2023 Feb; 20(1):8. PubMed ID: 36750835
[TBL] [Abstract][Full Text] [Related]
37. Fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1.
Hu Z; Giguel F; Hatano H; Reid P; Lu J; Kuritzkes DR
J Virol; 2006 Jul; 80(14):7020-7. PubMed ID: 16809307
[TBL] [Abstract][Full Text] [Related]
38. Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco.
El Annaz H; Recordon-Pinson P; Tagajdid R; Doblali T; Belefquih B; Oumakhir S; Sedrati O; Mrani S; Fleury H
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):944-8. PubMed ID: 21919803
[TBL] [Abstract][Full Text] [Related]
39. Clinical and Public Health Implications of HIV- Genetic Diversity and Drug Resistance Mutations in Angola: A Systematic Review.
Sebastião CS; Morais J; Brito M
AIDS Rev; 2020 Oct; 23(1):48-56. PubMed ID: 33105474
[TBL] [Abstract][Full Text] [Related]
40. Ultrasensitive detection of minor drug-resistant variants for HIV after nevirapine exposure using allele-specific PCR: clinical significance.
Rowley CF; Boutwell CL; Lee EJ; MacLeod IJ; Ribaudo HJ; Essex M; Lockman S
AIDS Res Hum Retroviruses; 2010 Mar; 26(3):293-300. PubMed ID: 20334564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
